Cointime

Tripod Preclinical Research Laboratories

company

About

Tripod provides preclinical research services for global pharma companies, R&D enterprises and institutes and medical device developers.

Highlights

Total Funding Amount
¥1B
Funding Rounds
2
Investors
3

Details

Last Funding Type
Secondary Market
Industries
Biopharma,Pharmaceutical
Founded date
Jan 1, 2008
Operating Status
Active

Tripod is a Contract Research Organization in the biopharmaceutical space that provides preclinical research services for global pharma companies, R&D enterprises and institutes, and medical device developers. Tripod (TPR) is dedicated to nonclinical research (drug safety evaluation) for the candidates of new chemical entity (NCE), food additives, biologics，pesticides，veterinary drugs, and new cosmetics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥1B
Tripod Preclinical Research Laboratories has raised a total of ¥1B in funding over 2 rounds. Their latest funding was raised on Nov 5, 2021 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 5, 2021 Series Unknown ¥1B 2 Ruihua Venture Capital
Lilly Asia Ventures 		— Detail
Aug 1, 2018 Secondary Market — 1 Wuhan Lihe Chemical New Material — Detail

Investors

Number of Lead Investors
Number of Investors
3
3
Tripod Preclinical Research Laboratories is funded by 3 investors. Ruihua Venture Capital and Lilly Asia Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Ruihua Venture Capital Yes Series Unknown
Lilly Asia Ventures Yes Series Unknown
Wuhan Lihe Chemical New Material Yes Secondary Market
Cointime
เนื้อหา
บริษัท